1. Cancer Statistics, 2003;Jemal;CA Cancer J Clin,2003
2. Improvements in survival and clinical benefits with gemcitabine in first line therapy for patients with advanced pancreatic cancer;Burris;J Clin Oncol,1997
3. A phase III study of gemcitabine in combination with 5-FU versus gemcitabine alone in patients with advanced pancreatic carcinoma;Berlin;Proc Am Soc Clin Oncol,2001
4. A phase III trial comparing gemcitabine plus cisplatinum versus gemcitabine alone in advanced pancreatic carcinoma;Heinemann;Proc Am Soc Clin Oncol,2003
5. A randomized phase III study comparing efficacy and safety of gemcitabine and irinotecan to gemcitabine alone in patients with locally advanced or metastatic pancreatic cancer who have not received prior systemic therapy;Rocha-Lima;Proc Am Soc Clin Oncol,2003